Skip to main content
Premium Trial:

Request an Annual Quote

Personalis, Ono Pharmaceutical, Japan National Cancer Center Partner on Opdivo Rectal Cancer Trial

NEW YORK – Personalis said Tuesday that it has partnered with Ono Pharmaceutical and Japan's National Cancer Center to assess its minimal residual disease platform in a study of Opdivo (nivolumab) in resectable rectal cancer with mismatch repair deficiency.

Opdivo was jointly developed by Ono and Bristol Myers Squibb.

During the study, called VOLTAGE-2, Personalis will analyze samples from both tumor tissue and plasma circulating tumor DNA using its ImmunoID NeXT assay and NeXT Personal MRD platform.

Investigators intend to compare MRD test results with standard of care imaging and drug response data, assessing whether an MRD-negative result could serve as a surrogate marker of clinical complete response.

Richard Chen, Personalis' chief medical officer, said in a statement that the company believes data from the study will help it advance NeXT Personal for use in both rectal cancer and other tumor types.

Ono will provide Opdivo for the collaboration while National Cancer Center Hospital East will recruit patients and conduct the clinical trial.

Financial terms of the partnership were not disclosed.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.